Frontiers in Immunology (Sep 2022)

Utilizing mast cells in a positive manner to overcome inflammatory and allergic diseases

  • Zhongwei Zhang,
  • Peter B. Ernst,
  • Peter B. Ernst,
  • Peter B. Ernst,
  • Hiroshi Kiyono,
  • Hiroshi Kiyono,
  • Hiroshi Kiyono,
  • Hiroshi Kiyono,
  • Hiroshi Kiyono,
  • Hiroshi Kiyono,
  • Hiroshi Kiyono,
  • Yosuke Kurashima,
  • Yosuke Kurashima,
  • Yosuke Kurashima,
  • Yosuke Kurashima,
  • Yosuke Kurashima,
  • Yosuke Kurashima

DOI
https://doi.org/10.3389/fimmu.2022.937120
Journal volume & issue
Vol. 13

Abstract

Read online

Mast cells (MCs) are immune cells widely distributed in the body, accompanied by diverse phenotypes and functions. Committed mast cell precursors (MCPs) leave the bone marrow and enter the blood circulation, homing to peripheral sites under the control of various molecules from different microenvironments, where they eventually differentiate and mature. Partly attributable to the unique maturation mechanism, MCs display high functional heterogeneity and potentially plastic phenotypes. High plasticity also means that MCs can exhibit different subtypes to cope with different microenvironments, which we call “the peripheral immune education system”. Under the peripheral immune education system, MCs showed a new character from previous cognition in some cases, namely regulation of allergy and inflammation. In this review, we focus on the mucosal tissues, such as the gastrointestinal tract, to gain insights into the mechanism underlying the migration of MCs to the gut or other organs and their heterogeneity, which is driven by different microenvironments. In particular, the immunosuppressive properties of MCs let us consider that positively utilizing MCs may be a new way to overcome inflammatory and allergic disorders.

Keywords